Has Frank Perrone received payments from drug or device companies?

Yes. Drug and device makers reported $2,618 in general payments to Frank Perrone across 175 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frank Perrone did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frank Perrone come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frank Perrone

Family Medicine · Philadelphia, PANPI 1750345880

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 175 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,245 and has fallen 65.4% since, to $431 in 2021.

$2,618in general payments, 2019–2025

Across 175 payments — averaging $14.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$405
AbbVie$278
Amarin Pharma, Inc.$276
Pfizer$258
Novo Nordisk$236
Johnson & Johnson$176
plus $989 from 16 others

What the payments were for

Food & beverage$2,607100%
Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	24	$405
AbbVie(2 entities)	27	$278
Amarin Pharma, Inc.	13	$276
Pfizer	22	$258
Novo Nordisk	18	$236
Johnson & Johnson(2 entities)	5	$176
Amgen	8	$155
Merck	19	$141
Takeda Pharmaceuticals U.S.A., Inc.	9	$141
Novartis	1	$100
Boehringer Ingelheim	4	$63
Arbor Pharmaceuticals, Inc.	4	$62
Kowa Pharmaceuticals America, Inc.	4	$55
Nestle Healthcare Nutrition Inc.	3	$54
AstraZeneca	3	$45
Teva Pharmaceuticals USA, Inc.	2	$45
Biohaven Pharmaceuticals, Inc.	2	$33
Lilly USA, LLC	2	$27
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$27
Althera Pharmaceuticals LLC	1	$18
Eisai Inc.	1	$13
E.r. Squibb & Sons, L.L.C.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Vascepa$125
ANORO$125
INVOKANA$124
ENTRESTO$100

How this compares

$2,618 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania →

Other family medicine in Philadelphia

Deborah WittPhiladelphia$226K
Michael AttanasioPhiladelphia$214K
Jonah MinkPhiladelphia$145K
Celia EzidiegwuPhiladelphia$118K
Glenn RosenPhiladelphia$61K
Jessica DefflerPhiladelphia$56K
Casey LaffertyPhiladelphia$55K
Margot SavoyPhiladelphia$31K
Neil SkolnikJenkintown$904K
Lisa EspinozaNew Hope$722K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →